Meet Sisi Chen, Winner of the 2021 SLAS Innovation Award

Dr. Siyu (Sisi) Chen, the Director of the Single-Cell Profiling and Engineering Center (SPEC) at the California Institute of Technology, was awarded the 2021 SLAS Innovation Award for her presentation on “Defining the Breadth and Specificity of Drug Response in Heterogeneous Immune Cell Populations” at the SLAS 2021 International Conference and Exhibition. The Innovation Award […]

Drug Target Review Set to Debut Virtual Workshop on Cellario™ October 12, 2022

Drug Target Review, a leading source for news and information in the life sciences industry, has prepared a workshop and tutorial on Cellario™, a laboratory automation software created by HighRes Biosolutions. The event is scheduled for October 12th and will feature a panel of three technical experts and instructors from HighRes Biosolutions. The free and […]

Emma Chory Wins 2022 SLAS Innovation Award

Emma J. Chory, a post-doctoral fellow in the Sculpting Evolution laboratory of MIT, was recently awarded the 2022 SLAS Innovation Award for her presentation on “Phage and Robotics-Assisted Directed Evolution” at the SLAS 2022 International Conference and Exhibition. The Innovation Award is one of six given out each year by The Society for Laboratory Automation […]

Dotmatics Collaborates with HighRes Biosolutions to Provide Single Software Interface for Lab Digitalization

  Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN Bishop’s Stortford, UK, and  Beverly, MA, 25 January 2021: Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory […]

HighRes Biosolutions and Novo Nordisk Partner to Transform Drug Discovery in Automated Lab of the Future

Beverly, US, 24 January 2020: HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large […]

HighRes Biosolutions and TetraScience integrate technology to provide R&D labs with next-generation lab automation.

BEVERLY, Mass. and BOSTON, May 22, 2019 /PRNewswire/ — HighRes Biosolutions and TetraScience announce a new partnership to integrate their flagship products to automate data collection and manipulation processes in life sciences lab automation. The integration streamlines data collection, aggregation, and transportation from HighRes’ robotics platform, moving data automatically to downstream informatics applications via the TetraScience Data Integration Platform. Popular […]

Beverly pharma robotics company names new CEO

By Kelly J. O’Brien – Technology Reporter, Boston Business Journal December 20, 2018, 4:39pm EST Beverly-based HighRes Biosolutions Inc. has named a new CEO as it aims to expand the reach of its robotic arms throughout the pharmaceutical world. Ira Hoffman, formerly the company’s president, will become CEO of February 1, replacing current CEO Peter […]

Controlling Costs of Drug Discovery Through Automation

Written by: Peter Harris, CEO, HighRes Biosolutions The escalating cost of discovering new biopharmaceutical therapies is a well-known and long-standing problem. Recent estimates by the Tufts Center for the Study of Drug Development put the cost of developing and getting approval for a new drug just shy of $3 billion1. The underlying buildup of costs, […]

What’s the future of lab automation?

Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds. The use of automation and robotics in scientific research has been around for quite some time, starting […]

Request Info